| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director
2 companies
Cary Guy Vance is President and CEO at AVHHL, with reported holdings spanning 2 companies. Cary Guy Vance's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $675K at current prices.
Cary Guy Vance's largest disclosed position is in RCEL as Director, worth about $548K.
Cary Guy Vance has 4 Form 4 filings on record from June 2023 to May 2026, across 2 companies: President and CEO at AVITA Medical (AVHHL), 2026; Director at AVITA Medical (RCEL), 2023–2025.
The 9 reported transactions were 5 stock awards and 4 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria